­The last few years have seen an explosion of impressive clinical results in the field of immunotherapy, representing some of the most promising advancements in disease treatment. One immuno-oncology platform that has demonstrated incredible therapeutic potential is the bispecific T cell engager (BiTE) technology. This technology harnesses a patient’s...